Detalles de la búsqueda
1.
Eleven-month longitudinal study of antibodies in SARS-CoV-2 exposed and naïve primary health care workers upon COVID-19 vaccination.
Immunology
; 167(4): 528-543, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36065677
2.
Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.
BMC Med
; 19(1): 155, 2021 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34183003
3.
Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain.
BMC Med
; 19(1): 309, 2021 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34809617
4.
Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens.
J Clin Microbiol
; 59(2)2021 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33127841
5.
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity.
Nat Commun
; 15(1): 1051, 2024 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316751
6.
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers.
EBioMedicine
; 75: 103805, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032961
7.
Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts.
Front Immunol
; 13: 751705, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35154094
8.
The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity.
Front Immunol
; 12: 737083, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34539673
9.
SARS-CoV-2 sculpts the immune system to induce sustained virus-specific naïve-like and memory B-cell responses.
Clin Transl Immunology
; 10(9): e1339, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34504693
10.
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies.
Transl Res
; 232: 60-74, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33582244
Resultados
1 -
10
de 10
1
Próxima >
>>